Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01940094 · ClinicalTrials.gov registry record · Phase 3
The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
A Phase 3 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 3
- Development phase
- 159
- Enrollment target
NCT01940094: Completed Phase 3 study, sponsored by University of Pennsylvania.
NCT01940094 is a Phase 3 study that has completed, run by University of Pennsylvania. The registered enrollment target is 159 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01940094, a Phase 3 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 159 participants
- Enrollment target
Study Summary
This study is a multi-center randomized controlled trial to evaluate the effects of using low-dose prednisone as compared to stopping prednisone treatment entirely. Participants will be randomized 1:1 to taper their prednisone dose down to 5 mg/day or to 0 mg/day for the duration of the study (approximately six months) or until a study endpoint.
Interventions
- DRUG 5 mg Prednisone
- DRUG 0 mg Prednisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2014-02 |
| Est. Completion | 2024-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01940094
The ClinicalTrials.gov registry entry for NCT01940094 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5 mg Prednisone is the first listed.
NCT01940094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01940094 about?
NCT01940094 is a clinical study titled "The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach". This study is a multi-center randomized controlled trial to evaluate the effects of using low-dose prednisone as compared to stopping prednisone treatment entirely. Participants will be randomized 1:1 to taper their prednisone dose down to 5 mg/day or to 0 mg/day for the duration of the study (appro...
What is the current status of trial NCT01940094?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 159 participants. The study started on 2014-02. Estimated completion is 2024-12.
What interventions are being tested in trial NCT01940094?
The interventions under investigation include: 5 mg Prednisone (DRUG), 0 mg Prednisone (DRUG).
Who is sponsoring clinical trial NCT01940094?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.